UK Omicron 37,000 daily… Novavax vaccine emergency use review started

In the UK, the number of cases of Omicron, a new variant of Corona 19, was 37,101 with an additional 12,133 cases in one day on the 19th local time.

On this day, there were 82,886 new confirmed cases and 45 deaths. Last week, there were more than 93,000 people, but it decreased slightly because it was the weekend.

In the UK, as the number of omicrons is rapidly increasing, voices emphasizing the need for early strengthening of quarantine regulations are growing. Professor Mark Woolhouse, a member of the Scientific Pandemic Influenza Group on Modeling (SPI-M), which presents scientific modeling results related to COVID-19 to the government, said in an interview with Times Radio that there is still uncertainty regarding the severity of the micron mutation, but in preparation for a confirmed ‘tsunami’. He said it was right to have a plan. In Scotland, senior officials are mentioning that additional regulations could be introduced by the new year.

While performances such as musicals and soccer matches have been canceled one after another, and restaurants are complaining about damage from the cancellation of meetings, the older brother of former Labor Party leader Jeremy Corbyn, Pierce Corbyn, 74, has been arrested on charges of encouraging the setting of a congressman’s office during protests against the COVID-19 lockdown. It was also a pig.

Meanwhile, while Omicron is rapidly increasing mainly in Europe, the European Medicines Agency (EMA) is holding a meeting today to approve the emergency use of a COVID-19 vaccine developed by US pharmaceutical company Novavax.

According to local media, it is known that the European Medicines Agency will hold an advisory group meeting today local time to decide whether to approve the emergency use of the COVID-19 vaccine developed by Novavax.

The European Medicines Agency also announced on its website that it will hold an extraordinary meeting today to hold a meeting related to the emergency use approval for Novavax’s COVID-19 vaccine and announce the results of the review.

If Novavax’s COVID-19 vaccine receives emergency use approval from the European Medicines Agency today, local media reported that it is highly likely to receive emergency use approval from the World Health Organization (WHO) within this week.

The World Health Organization approved the emergency use of the COVID-19 vaccine produced by Novavax through the Serum Institute of India (SII) on the 17th local time.

In addition, Novavax announced that it is conducting an experiment to see if it is effective against Omicron, a new mutant virus for COVID-19, and will announce the results soon.

[사진 출처 : 연합뉴스]